News

Investors Alert: Important Updates on Paragon 28, Inc. Lawsuit

Investors Alert: Important Updates on Paragon 28, Inc. Lawsuit

Deadline for Filing in Paragon 28, Inc. Class Action Lawsuit

Investors are alerted to the significant deadline of November 29, 2024, which is fast approaching for anyone interested in filing a lead plaintiff motion regarding the class action lawsuit against Paragon 28, Inc. This legal case represents those who purchased Paragon's common stock under the ticker FNA, during a designated time period.

Understanding the Class Period and Legal Rights

The critical class period spans from May 5, 2023, to August 8, 2024. Investors who believe they have suffered losses related to their investments in Paragon are encouraged to reach out to legal experts at the Law Offices of Howard G. Smith. Their team is ready to assist clients in exploring their legal rights and options in this ongoing case.

Important Financial Disclosures by Paragon

On July 30, 2024, Paragon 28, Inc. disclosed that their financial reports issued in both 2023 and 2024 contained errors and therefore should no longer be considered reliable. This revelation led to the need for restatements due to significant weaknesses identified in their internal controls over financial reporting, which raised many concerns among investors.

Impact of Financial Restatements on Stock Prices

The repercussions of this announcement were immediate and detrimental. Paragon's stock value plummeted by $1.24, which equates to a staggering 13.7% drop, concluding at $7.79 per share on July 31, 2024. The financial turmoil did not cease there; further disclosures on August 8, 2024, regarding restated annual figures revealed additional understatements and inaccuracies, resulting in another 20.1% decrease in Paragon's stock price, falling to $6.64 per share.

Allegations Against Paragon’s Management

The class action lawsuit centers around allegations that the management of Paragon made misleading statements about the financial state of the company. The complaint contends that key facts regarding the company's financial health were not disclosed, which misled investors. Specifically, there were serious errors in financial statements, and the company did not adequately communicate the extent of internal control weaknesses.

Next Steps for Affected Investors

Those who acquired common stock in Paragon during the class period can seek to have the court appoint them as the lead plaintiff. It’s essential to recognize that investors need not act immediately to participate in this class action, as they can choose to maintain their status as absent members of the class. Having legal representation is advisable, and investors have the option to consult with the Law Offices of Howard G. Smith for guidance.

Contact Information for Inquiries

For any inquiries related to the class action lawsuit or if you have questions regarding your rights and interests concerning Paragon 28, Inc., you can reach out to Howard G. Smith, Esquire. His office located at 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania, is available via telephone at (215) 638-4847 or toll-free at (888) 638-4847. Feel free to send an email to howardsmith@howardsmithlaw.com for further assistance.

Frequently Asked Questions

What is the class action lawsuit against Paragon 28, Inc. about?

The lawsuit involves claims by investors who believe they suffered losses due to misleading financial information provided by Paragon 28, Inc.

What is the deadline to file a motion as lead plaintiff?

The deadline to file a lead plaintiff motion is November 29, 2024.

What should I do if I invested in Paragon during the class period?

If you invested in Paragon between May 5, 2023, and August 8, 2024, consider contacting legal representation for assistance regarding your rights.

Who can be the lead plaintiff in this case?

Investors who meet specific legal requirements can seek appointment as the lead plaintiff in the class action lawsuit.

How can I contact the Law Offices of Howard G. Smith?

You can reach them by phone at (215) 638-4847 or by email at howardsmith@howardsmithlaw.com for inquiries about the case.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Supply Maverick Simplifies Global Shipping Processes

Updated Category News Views 5

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 4

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
NYSE Reflects on 9/11: Honoring Lives and Legacy

Updated Category News Views 6

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Continue Reading
Jari Spirits Set to Shake Up U.S. Market After Big Wins

Updated Category News Views 4

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Continue Reading
2026 Buy-Side Index Reveals State Market Variance

Updated Category News Views 6

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 5

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 6

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading
QuickFi Nabs Top Finovate Award for Fourth Time

Updated Category News Views 5

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 3

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Graft versus Host Disease Market Growth 2024-2034

Updated Category News Views 133

Growth Insights in the Graft versus Host Disease Market The Graft versus Host Disease (GvHD) market is set to experience significant growth in the coming years. This upsurge is primarily due to the rising use of branded therapies like JAKAFI, IMBRUVICA, ORENCIA, and REZUROCK. Predictions suggest a robust Compound Annual Growth Rate (CAGR) of 9.9% during this period,...

Continue Reading
Midland Exploration Completes Successful Private Placement Funding

Updated Category News Views 218

Midland Exploration Achieves Successful Closing of Private Placement Montreal-based Midland Exploration Inc. is thrilled to announce the successful completion of a non-brokered private placement, raising a total of $3,037,811. This financial boost comes from issuing nearly five million common shares categorized as “flow-through shares” at the price of $0.56 per share,...

Continue Reading
Innovative Fire Safety Strategy: SDGE's Goats in Action

Updated Category News Views 503

Innovative Fire Safety Strategy: SDGE's Goats in Action San Diego Gas & Electric (SDGE) is taking an innovative approach to wildfire prevention that combines a time-honored natural method with modern technology. The company recently launched a new social media initiative, complete with an Instagram account, dedicated to showcasing the role of goats in reducing wildfire...

Continue Reading
eHealth, Inc. Grants New Stock Units to Employees Under Nasdaq Rules

Updated Category News Views 98

eHealth, Inc. Issues Inducement Grants for New Employees In recent news, eHealth, Inc. (Nasdaq: EHTH), a prominent player in the health insurance marketplace, has taken a significant step to enhance its workforce by granting inducement stock unit awards. This decision marks a notable move in the company's strategy to attract and retain talented individuals within the...

Continue Reading
Novo Nordisk's New Pricing Strategy Signals Market Adaptation

Updated Category News Views 368

Novo Nordisk Introduces Cost-Effective Solutions Novo Nordisk A/S (NYSE: NVO) has recently made headlines with its innovative pricing strategy aimed at making its popular weight loss medications, Wegovy and Ozempic, more affordable for patients. In an effort to tackle the escalating competition in the obesity treatment market, the company is offering a limited-time...

Continue Reading